Why the study?
Does the addition of erythromycin to warfarin therapy increase the anticoagulant response?
Does the addition of erythromycin to warfarin therapy increase the anticoagulant response?
The addition of erythromycin to warfarin therapy can significantly increase the anticoagulant response, highlighting a potentially significant drug-drug interaction.
May warrant INR monitoring with erythromycin coadministration; hypothesis-generating and requires prospective confirmation.
In the patient described, marked exacerbation of the hypoprothrombinemic response to warfarin coincided with the addition of erythromycin to the drug regimen. A subsequent study in rats provided evidence that erythromycin is capable of increasing the anticoagulant response to single doses of warfarin. On the basis of case findings, preliminary laboratory data, and related clinical data we conclude that the interaction between warfarin and erythromycin is one of potential significance.
No takes yet. Share an insight, caveat, or question.
Schwartz et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: